Hospital mortality over time in patients with specific complications of cirrhosis

Liver International

Volumn 33, Issue 6, 2013, Pages 828-833

  Vergara, Mercedes ^a,c   Clèries, Montse ^b   Vela, Emili ^b   Bustins, Montserrat ^b   Miquel, Mireia ^a,c   Campo, Rafael ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Servei Català de la Salut ^*  (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Ascites; Bacterial spontaneous peritonitis; Cirrhosis; Encephalopathy; Hepatorenal syndrome; Hospital mortality; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BRAIN DISEASE; EMERGENCY CARE; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; STOMACH VARICES BLEEDING;

AGED; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPAIN; TIME FACTORS;

EID: 84878920568     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12137     Document Type: Article

References (40)

1. Singla A, Hart JL, Li Y, Tseng JF, Shah SA. Hospitalization for complications of cirrhosis: does volume matter? J. Gastrointest. Surg. 2011; 15: 330-5.
2. Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin. Gastroenterol. Hepatol. 2007; 5: 1092-9.
3. Sorensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol 2003; 56: 88-93.
4. Planas R, Balleste B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004; 40: 823-30.
5. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003; 124: 1016-20.
6. Berman K, Tandra S, Forssell K, et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin. Gastroenterol. Hepatol. 2011; 9: 254-9.
7. Corredoira JM, Ariza J, Pallares R, et al. Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis 1994; 13: 19-24.
8. Viasus D, Garcia-Vidal C, Castellote J, et al. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) 2011; 90: 110-8.
9. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152: 1818-24.
10. Feltracco P, Brezzi M, Barbieri S, et al. Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems. Transplant. Proc. 2011; 43: 1079-84.
11. Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr. Opin. Crit Care 2011; 17: 165-9.
12. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 1282-9.
13. Gundling F, Seidl H, Schmidtler F, et al. Nonhepatic cancer in liver cirrhosis: a retrospective study of prevalence, complication rate after specific oncological treatment, follow-up and prognostic predictors of outcome in 354 patients with cirrhosis. Anticancer Res 2011; 31: 2931-8.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 1987; 40: 373-83.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
16. Hosmer DW, Hosmer T, Le CS, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16: 965-80.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
18. Alsultan MA, Alrshed RS, Aljumah AA, et al. In-hospital mortality among a cohort of cirrhotic patients admitted to a Tertiary Hospital. Saudi.J.Gastroenterol 2011; 17: 387-90.
19. Alonso FT, Garmendia ML, Aguirre M, Searle J. Mortality trend from liver cirrhosis in Chile from 1990 to 2007. Rev Med Chil 2010; 138: 1253-8.
20. Eker HH, van Ramshorst GH, de GB, et al. A prospective study on elective umbilical hernia repair in patients with liver cirrhosis and ascites. Surgery 2011; 150: 542-6.
21. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188: 580-3.
22. Alqahtani SA, Larson AM. Adult liver transplantation in the USA. Curr. Opin. Gastroenterol. 2011; 27: 240-7.
23. Alonso EM, Gonzalez-Vallina R, Whitington PF. Update of pediatric liver transplantation. Eur J Pediatr 1992; 151(Suppl 1): S23-31.
24. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-75.
25. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34: 46-52.
26. Fan ST, Mau LC, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011; 253: 745-58.
27. Les I, Doval E, Garcia-Martinez R, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol 2011; 106: 1081-8.
28. Tseng PL, Lu SN, Tung HD, et al. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. J. Viral Hepat. 2005; 12: 386-92.
29. Gines P. Pharmacological management of hepatorenal syndrome: lessons from non-responders. J Hepatol 2011; 55: 268-9.
30. Montoliu S, Ballesté B, Planas R, et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol. 2010; 8: 616-22.
31. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999 Aug 5; 341: 403-9.
32. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N.Engl.J.Med 2010; 362: 1071-81.
33. Conthe P, Garcia J, Pujol R, et al. Consensus for hospital discharge reports in medical specialities. Med Clin (Barc) 2010; 134: 505-10.
34. Campillo C. Clinical registries: practical recommendations for its creation. Med Clin (Barc) 2011; 136: 163-8.
35. Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol. Hepatol. 2011; 9: 260-5.
36. Corneille MG, Nicholson S, Richa J, et al. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis. J Trauma 2011; 71: 6-11.
37. Chen WT, Lin CY, Sheen IS, et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol 2011; 17: 2120-5.
38. Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig.Dis.Sci. 2011; 56: 977-87.
39. Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009; 43: 580-5.
40. Sola R, Alvarez MA, Balleste B, et al. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Liver Int. 2006; 26: 62-72.